|
No images? Click here IDCRC Newsletter: December 2025
As 2025 comes to a close, the IDCRC Leadership Group would like to extend their gratitude for your efforts and dedication this year. We wish our network and partners a happy and safe holiday season. We will see you in 2026! “Wishing everyone a wonderful holiday season with friends and family. I want to thank you for your tremendous contributions to the goals and studies of the IDCRC over the last year.”—David Stephens, MD, IDCRC PI and LG chair (pictured left)
"With the winter holidays and the end of 2025 approaching, I want to thank everyone for your hard work and enthusiasm this year. It is my sincere pleasure to work with all of you. May you and your families have a wonderful holiday season!"—Jim Campbell, MD, MS, LG vice chair (pictured middle) "As a tumultuous year comes to an end, I am grateful to all of the dedicated colleagues who make our IDCRC network such a terrific team. Thank you for your ongoing support for the science and our study participants."—Jodie Dionne, MD, MSPH, LOC director (pictured right) IDCRC Spotlight: PROMISE Study
This month's IDCRC investigator spotlight features Rebecca C. Brady, MD, (Cincinnati Children's Hospital Medical Center), site principal investigator for the PROMISE study. This study is evaluating the effects of maternal vaccination and infant monoclonal antibody administration on RSV antibody levels in mothers and infants, providing essential insights into how these interventions function independently and in combination.
Help us commit to our New Year's resolution! As we wrap up a great 2025, we want to start the new year strong. Help us with our resolution to spotlight YOU in the upcoming year. With our expansive network of investigators, staff, and administrative team members, we know you have great news and updates that deserve some attention.
Not sure what to submit? Below are a few ideas...
If you answered YES to any of the questions above or have another idea in mind for a future IDCRC newsletter, contact our team! PublicationsNOTE: Please include the following citation in any publications resulting from direct or indirect IDCRC support: "Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." TrainingIDCRC Mentee Profile: Sabiha Rabia Hussain, MD
Sabiha Rabia Hussain, MD, is a third-year pediatric infectious diseases fellow at Texas Children's Hospital/Baylor College of Medicine. Her research focuses on the nasal microbiota of preterm infants prior to NICU discharge and during acute respiratory viral infections.
NewsMedscape | Real-World Data for Nirsevimab, Maternal RSV Vaccine Show Sizeable Drop in Infant Hospitalizations In the first respiratory syncytial virus (RSV) season with widespread availability of two preventive options against the virus, RSV-related hospitalizations of young infants declined substantially, and both products showed real-world effectiveness similar to what was seen in clinical trials, according to two studies presented at the Infectious Disease Week (IDWeek) 2025 Annual Meeting in Atlanta.
The data came from the New Vaccine Surveillance Network (NVSN), which prospectively enrolls children younger than 18 years old who have an emergency, outpatient, or inpatient visit for acute respiratory illness at one of the seven included sites in Rochester, Pittsburgh, Cincinnati, Nashville, Kansas City, Houston, and Seattle. The researchers analyzed trends from infants less than 6 months old who had a positive RSV PCR test, including those with other viral coinfections. IDSA | A View from the Trenches: Critical Information for Respiratory Virus Season with C. Buddy Creech, MD, MPH The IDSA's Congressional Briefing recording, "A View from the Trenches: Critical Information for Respiratory Virus Season," features physician speakers, including C. Buddy Creech, MD, MPH, Vanderbilt VTEU PI. Together, they discuss how their institutions are preparing for respiratory virus season, including predictions and vaccination recommendations. NBC News | Norovirus is spreading earlier again this year, wastewater data shows with Robert Atmar, MD
For over 30 years, norovirus outbreaks have been dominated by one strain, GII.4. Last year’s outbreaks were overwhelmingly caused by the variant GII.17, making up around 75% of outbreaks. The GII.17 strain has become more prevalent in several countries, including the United States, through the 2020s. The rise of GII.17 may explain why the 2024 spikes and this year’s spread started earlier in October, instead of winter. Dr. Robert Atmar, professor in the Department of Medicine at Baylor College of Medicine, said a combination of factors may have led to GII.17’s dominance. “The two possibilities are that something in the virus changed to make it more transmissible, or there were changes in the population that a larger proportion were susceptible,” he said. “And probably it’s a combination of both. But whether it’s going to persist this year, I think, is one of the big questions in our scientific community.” Georgia Trend | Carlos del Rio, MD, MACP, named one of Congratulations to Carlos del Rio, MD, MACP, Emory Vaccine Center VTEU co-PI, on being named one of Georgia Trend's 500 Most Influential Leaders in Healthcare. He receives this recognition for his decades of patient care, infectious disease and global health research, medical education, and healthcare administration.
Job PostingsNewly Posted! Infectious Diseases Research Job Openings
Visit the IDSA Career Center to browse other ID/HIV Medicine job postings. Funding Opportunities2026 Deadline: Georgia CTSA TL1 (T32-like) Clinical and Translational Research Training Program Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) *NEW* Notice of Special Interest (NOSI): Promoting Research and Development of Vaccines Against Enteric Viruses Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) 2027 Deadline: Notice of Special Interest (NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV) Notice of Special Interest (NOSI): Systems Modeling of Infection and Immunity Across Biological Scales Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery Annual MeetingSave the Date: 2026 Annual Meeting
Save the date! Next year's IDCRC Annual Meeting will take place on Wednesday, May 13, and Thursday, May 14, 2026. We look forward to seeing everyone then. Stay tuned for more details! IDCRC StudiesActive Studies Recruiting Volunteers
Fully Enrolled Studies in Follow-up
IDCRC Concept Quick StatsICP Status
EWG Assignment
ECP Status
Communication ResourcesPlease submit IDCRC news to idcrc@emory.edu for inclusion in the monthly newsletter and IDCRC.org.
|